These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 7961028

  • 1. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B, Shibamoto Y, Grujicic D, Stojanovic M, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J.
    J Neurooncol; 2001 Jan 01; 51(2):133-41. PubMed ID: 11386410
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M.
    Int J Radiat Oncol Biol Phys; 1993 Jan 15; 25(2):193-207. PubMed ID: 8380567
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Shibamoto Y.
    Am J Clin Oncol; 1995 Oct 15; 18(5):449-53. PubMed ID: 7572767
    [Abstract] [Full Text] [Related]

  • 10. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    J Neurooncol; 1994 Oct 15; 21(2):177-85. PubMed ID: 7861194
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
    Ogawa K, Ishiuchi S, Inoue O, Yoshii Y, Saito A, Watanabe T, Iraha S, Toita T, Kakinohana Y, Ariga T, Kasuya G, Murayama S.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):732-8. PubMed ID: 21420247
    [Abstract] [Full Text] [Related]

  • 13. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 01; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 14. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ.
    J Neurooncol; 2018 Mar 01; 137(1):39-47. PubMed ID: 29404979
    [Abstract] [Full Text] [Related]

  • 15. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):75-83. PubMed ID: 7721642
    [Abstract] [Full Text] [Related]

  • 16. Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.
    Lassen U, Kristjansen PE, Wagner A, Kosteljanetz M, Poulsen HS.
    J Neurooncol; 1999 Jun 30; 43(2):161-6. PubMed ID: 10533728
    [Abstract] [Full Text] [Related]

  • 17. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
    Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM.
    Cancer; 2001 Jul 15; 92(2):420-33. PubMed ID: 11466698
    [Abstract] [Full Text] [Related]

  • 18. Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
    Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A, Aleksandrovic J.
    J Neurooncol; 1999 Jun 15; 43(2):179-85. PubMed ID: 10533731
    [Abstract] [Full Text] [Related]

  • 19. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 20. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH, Hong YK, Yoon SC, Kim BS, Lee YS, Lee TK, Lee KS, Jeun SS, Kim MC, Park CK.
    Oncol Rep; 2007 Jun 15; 17(6):1359-64. PubMed ID: 17487391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.